Gregory A. Demopulos, M.D., is a distinguished figure in the biotechnology industry, serving as President, Chief Executive Officer, and Chairman of the Board at Omeros Corporation. Dr. Demopulos co-founded Omeros in 1994 and has been instrumental in guiding the company's growth and development into a leading clinical-stage biopharmaceutical firm. Under his leadership, Omeros has successfully advanced multiple drug candidates through clinical trials, with a focus on inflammation, coagulopathies, and disorders of the central nervous system. His strategic vision has been pivotal in securing key partnerships and driving the company's innovative research and development efforts. Dr. Demopulos brings a wealth of experience and expertise to his role at Omeros. He completed his undergraduate studies at Stanford University and earned his medical degree from the University of Washington. He further honed his skills through a residency in orthopedic surgery at the University of Washington and a fellowship in trauma surgery at the University of Maryland. Before founding Omeros, Dr. Demopulos served as a faculty member at the University of Washington and held various leadership positions in the medical field. His extensive background in both clinical practice and research has uniquely positioned him to lead Omeros in its mission to develop novel therapeutics that address unmet medical needs. As the head of Omeros Corporation, Dr. Demopulos has overseen the company's transition from a research-focused entity to a commercially successful enterprise. One of his notable achievements includes the FDA approval of Omidria, a groundbreaking ophthalmic drug that has significantly improved patient outcomes in cataract surgery. Dr. Demopulos continues to steer Omeros towards new frontiers, with ongoing clinical programs targeting a range of serious medical conditions. His commitment to innovation and patient care remains at the forefront of his leadership, ensuring that Omeros remains at the cutting edge of biopharmaceutical advancements.